Canada markets close in 1 hour 50 minutes

Regencell Bioscience Holdings Limited (RGC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.8000+0.3000 (+6.67%)
As of 10:02AM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-06-30
2022-06-30
2021-06-30
2020-06-30
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
1,582
1,582
2,512
438.323
386.23
Selling General and Administrative
4,692
4,692
5,106
943.039
426.141
Total Operating Expenses
6,274
6,274
7,618
1,381
812.371
Operating Income or Loss
-6,274
-6,274
-7,618
-1,381
-812.371
Total Other Income/Expenses Net
211.342
211.342
23.215
34.617
-
Income Before Tax
-6,062
-6,062
-7,595
-1,347
-812.371
Income Tax Expense
0
0
0
0
0
Income from Continuing Operations
-6,062
-6,062
-7,595
-1,347
-812.371
Net Income
-5,871
-5,871
-7,446
-1,347
-812.371
Net Income available to common shareholders
-5,871
-5,871
-7,446
-1,347
-812.371
Basic EPS
-0.45
-0.45
-0.58
-0.11
-0.06
Diluted EPS
-0.45
-0.45
-0.58
-0.11
-0.06
Basic Average Shares
13,013
13,013
12,806
12,642
12,642
Diluted Average Shares
13,013
13,013
12,806
12,642
12,642